Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Liabilities and Shareholders Equity (2016 - 2025)

AtriCure (ATRC) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $654.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 7.36% to $654.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 billion, a 3.18% increase, with the full-year FY2025 number at $654.2 million, up 7.36% from a year prior.
  • Liabilities and Shareholders Equity was $654.2 million for Q4 2025 at AtriCure, up from $635.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $701.1 million in Q2 2021 to a low of $581.9 million in Q3 2022.
  • A 5-year average of $613.2 million and a median of $604.6 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 32.62% in 2021, then decreased 16.42% in 2022.
  • AtriCure's Liabilities and Shareholders Equity stood at $615.3 million in 2021, then decreased by 4.85% to $585.4 million in 2022, then rose by 4.87% to $613.9 million in 2023, then dropped by 0.75% to $609.3 million in 2024, then rose by 7.36% to $654.2 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Liabilities and Shareholders Equity are $654.2 million (Q4 2025), $635.4 million (Q3 2025), and $608.8 million (Q2 2025).